Drugs for restless foot syndrome increases 'deviant' sexual behaviors

Patients who have been prescribed for restless feet syndrome (RLS) have said that doctors did not warn them about the significant side effects of the drug – including dangerous sexual behaviors and forced gambling.

One woman recalls that she left her home in the early hours of search of sex, while another said that after creating a gambling addiction, she paid £ 80,000.

The drug ropiniroole, described as “dopamine agonist” and offered in the NHS for conditions that affect our movements, but Hideing Hidicance Hiden Hine warns that drugs are associated with pathological gambling, eating excessive, mandatory and over -sexual purchases.

According to the NHS, RLS creates a “creepy or creeping” feeling in the legs, calves and thighs, as well as excessive insistence on moving them.

These drugs are designed to work on a part of the brain that controls the movement, but the same part of the brain regulates pleasure and reward. This means that people can enjoy the irritating activities.

However, 20 women have told the BBC that doctors did not warn them of the side effect, which many say they have ruined their lives.

The internal report of the GSK drug company, which makes the drug, shows that the manufacturer was aware of the transplant with provocative behaviors in 2003. This information was shared with a drug regulator.

GSK says the pamphlets in medical packaging have cited “changed” sexual interest since 2007.

A 2003 report by GSK manufacturers showed some of the dangerous side effects of the drug, but many patients were unaware (Reuters)

A woman, who was named only as chlorine, told the BBC that she created RLS during pregnancy and was prescribed ropinol after childbirth.

Initially, the drug was surprising, resting his rest and helping him to sleep. But after a year he began to be strange sex experiences.

He recalled that he was wearing his home with a jacket, ignoring and blinking to his chest to any man he could. Claire, who had a partner, said he did so in dangerous places.

“There is an element left in your mind that you know what you are doing is wrong, but it affects you as much as you don’t know,” he told the BBC.

It took years for her to connect these demands with the drug, but she explained that the demands were stopped almost immediately after the drug was stopped. Now, he fights with “shame” and the knowledge that has put himself in danger.

Another woman, who found herself in 80,000 pounds, said she had referred to her recent gambling behavior when prescribing an agonist dopamine II, but had not been warned about the possible side effect of compulsory behavior.

The GSK report since 2003, seen by the BBC, described “deviant behavior” in two men prescribing Ropinrol for Parkinson’s disease. One was a 63 -year -old man who attacked a seven -year -old girl after creating a “sexual desire” who resulted in custody.

The second case was a 45 -year -old man who took “unknown behavior” actions. His sex drive has been reported after his treatment.

GSK admitted that your medicine can have a strong motivation for gambling, uncontrollable shopping, eating too much and over -the -work activity (Foot)

In 2011, a class action against GSK was carried out by four Parkinson’s disease. They said ropinol resulted in broken relationships and gambling debt.

They also said that despite the links to such behaviors in medical studies in the early 2000s, GSK did not include this alert in its medical pamphlets until 2007. The class action was settled, but GSK rejected the responsibility.

In a statement GSK said Independent This case – the Ropinirole brand – has been prescribed more than 17 million treatments since 1996 and has done “extensive clinical tests”.

Requip is said to be an effective treatment for Parkinson’s and RLS, with “completely specific safety specifications”.

“Like all medications, Requip has potential side effects, and these are clearly stated in the prescribed information. Patients should only be guided by a medical specialist,” GSK spokesman added.

He added: “After the 2003 research, when a link to” diverted “sexual behaviors, the results were shared with health officials and had informed updates to prescribe information.

GSK said the patient’s current information leaflet for ropinroll refers to a change in sexual interest. There is also a strong motivation for gambling, uncontrollable purchases, eating too much and over -theed activity.